Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-08-14
2007-08-14
Swope, Sheridan (Department: 1656)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S070100, C435S071100, C435S189000, C435S252300, C435S252330, C435S325000
Reexamination Certificate
active
10698228
ABSTRACT:
A protein having ribonucleotide reductase activity, DNA encoding the protein, antibodies to these and the like are disclosed. The protein, DNA and antibodies are useful in the prevention, treatment and diagnosis, etc. of cancer.
REFERENCES:
patent: 5891621 (1999-04-01), Chabin et al.
patent: 0726 277 (1996-08-01), None
patent: A-10-14582 (1998-01-01), None
patent: WO99/06552 (1999-11-01), None
patent: WO 00/15799 (2000-03-01), None
N—Geneseq—Dec. 16, 2004 Database Accession No. AAA12411 Jul. 25, 2000 from WO200015799 Tang et al. Mar. 23, 2000 priority 60/128,660 filed Apr. 8, 1999. Alignment with Seq. Id No. 1.
N—Geneseq—Dec. 16, 2004 Database Accession No. AAA12411 Jul. 25, 2000 from WO200015799 Tang et al. Mar. 23, 2000 priority 60/128,660 filed Apr. 8, 1999. Alignment with Seq. Id No. 2.
Galye et al, Identification of regions in interleukin-1 alpha important for activity. J Biol Chem. Oct. 15, 1993;268(29):22105-11.
Whisstock et al, Prediction of protein function from protein sequence and structure. Q Rev Biophys. Aug. 2003;36(3):307-40. Review.
Fernandez-Trigo et al, Prognostic implications of chemoresistance-sensitivity assays for colorectal and apprendiceal cancer. Am J Clin Oncol. Oct. 1995;18(5):454-60.
European Patent Office Communication mailed Apr. 19, 2004 (3 pp.) for corresponding application No. 00940840.2.
Pavloff, Nadine, et al “Sequence Analysis of the Large and Small Subunits of Human Ribonucleotide Reductase”,DNA Sequence—J. DNA Sequencing and Mapping, (1992), vol. 2, No. 4-pp. 227-234. GenBank Accession No. X59618).
Reichard, Peter, “From RNA to DNA, Why So Many Reibonucleotide Reductases?”,Science(1993) vol. 260, No. 5115, 1773-1777.
Tanaka, Hiroshi, et al., “A Ribonucleotide Reductase Gene Involved In a p53-Dependent Cell-Cycle Checkpoint for DNA Damage”,Nature, (2000), vol. 404, No. 6773, p. 42-49.
Ansorge et al, T46249 hypothetical protein DKFZp761E1312.1. Feb. 4, 2000. EMBL Acc# AL137348. Alignment with Seq. Id No. 1.
Pavloff et al, Ribonucleoside-diphosphate reductuase M2 chain. Jul. 1, 1993. SwissProt Acc# P31350. Alignment with Seq Id No. 1.
Duclert et al, Human secreted protein encoded by 5′Est Seq Id No.: 88. ID# AAY13074 from WO9906552-A2. 22=Jun. 1999. Alignment with Seq. Id No. 1.
Yumi et al, Ribonucleotide Reductase Abstract from JP10014582A. Jan. 20, 1998 and attached IDS for PCT/JP00/04189.
Arakawa Hirofumi
Nakamura Yusuke
Tanaka Hiroshi
Conlin David G.
Edwards Angell Palmer & & Dodge LLP
Russett Mark D.
Swope Sheridan
Takeda Pharmaceutical Company Limited
LandOfFree
Protein having ribonucleotide reductase activity and DNA... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein having ribonucleotide reductase activity and DNA..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein having ribonucleotide reductase activity and DNA... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3840944